Researchers have evaluated the downstream effects of psilocybin using [11C]raclopride PET to measure dopamine release and [18F]fluorodeoxyglucose PET to measure changes in glycolysis and brain metabolism.

Authors

• Person: Not available Organization: Nature
  Neuroimaging in psychedelic drug development: past, present, and ...

Sources

• Neuroimaging in psychedelic drug development: past, present, and ... www.nature.com Nature via serper

Referenced by nodes (4)

• psilocybin concept
• dopamine concept
• PET concept
• glycolysis concept